FDA - 2/95 - Xconomy

Entry	Author	Date	Location
J&J Opens San Diego Biotech Startup Center, Says ‘No Strings Attached’	Luke Timmerman	01/18/12	San Diego
Sanofi CEO Viehbacher on Stirring Innovation in the Era of R&D Cutbacks	Luke Timmerman	01/17/12	National
Me-Too Drugs	Kleanthis Xanthopoulos	01/11/12	San Diego
The Situation at the FDA: We Are All to Blame	Bryan Roberts	01/10/12	San Francisco
Canaan Partners Survives VC Turmoil, Raises New $600M Tech/Biotech Fund	Luke Timmerman	01/09/12	San Francisco
Five Myths You’ll Hear This Week at the JP Morgan Healthcare Conference	Luke Timmerman	01/09/12	National
San Diego Life Sciences Roundup: Isis, Elevation, Proacta, and More	Bruce V. Bigelow	01/06/12	San Diego
Mirador Biomedical Gets FDA Green Light to Expand Use of Digital Sensor	Luke Timmerman	01/05/12	Seattle
JeNu Biosciences Raises $1.5M for Ultrasound to “Put Good Things in Skin”	Luke Timmerman	01/03/12	Seattle
VelQuest Bought by Accelrys for $35M	Gregory T. Huang	01/03/12	Boston
The Top 10 Traffic-Getting Stories at Xconomy San Diego	Bruce V. Bigelow	12/28/11	San Diego
Allozyne Raises More VC Cash, Looks to FDA Meeting After Poniard Deal Fizzles	Luke Timmerman	12/23/11	Seattle
Momenta, Baxter Team Up on Biosimilars	Erin Kutz	12/23/11	Boston
San Diego Life Sciences Roundup: Intellikine, Somaxon, and More	Bruce V. Bigelow	12/22/11	San Diego
The Move to Value-Based Pricing for Prescription Drugs	Michael Drummond	12/21/11	National
Zogenix Sets Timetable for New Painkiller Drug	Bruce V. Bigelow	12/20/11	San Diego
Anticipating FDA Clearance in 2012, Sotera Wireless Raises $12.2M	Bruce V. Bigelow	12/14/11	San Diego
AesRx Navigates “Valley of Death” to Get Sickle Cell Drug Into Trials	Arlene Weintraub	12/14/11	Boston
Seattle Genetics, Millennium Look to Broaden Reach of Hodgkin’s Drug	Luke Timmerman	12/09/11	Seattle
Affymax Passes FDA Panel Scrutiny, Looks to Challenge Amgen Anemia Drug	Luke Timmerman	12/07/11	San Francisco
Affymax Shares Climb As FDA Considers Wider Use for Anemia Drug	Luke Timmerman	12/05/11	San Francisco
FDA Clears Portable Insulin Pump from San Diego’s Tandem Diabetes	Bruce V. Bigelow	11/16/11	San Diego
Rhythm Adds Former Merck VP as CEO	Erin Kutz	11/09/11	Boston
Amylin and Eli Lilly Part Ways on Diabetes Drug; Alkermes Deal Intact	Bruce V. Bigelow	11/08/11	San Diego
The Cancer Drug Dark Ages Are Coming to an End	Luke Timmerman	10/31/11	National
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News	Erin Kutz	10/28/11	Boston
In a Detour From Device Strategy, Zogenix Edges Closer to New Drug Application	Bruce V. Bigelow	10/27/11	San Diego
Exelixis Passes Key Test With Lead Drug; Stock Soars	Luke Timmerman	10/24/11	San Francisco
Life Sciences 2031: What about 2011?	David Sable	10/20/11	New York
Vertex Seeks FDA Green Light for Cystic Fibrosis Drug, Second Potential Hit of Big Year	Luke Timmerman	10/19/11	Boston
Page 2 of 32	« previous page · next page »

Entry

Author

Date

Location

J&J Opens San Diego Biotech Startup Center, Says ‘No Strings Attached’

Luke Timmerman

01/18/12

San Diego

Sanofi CEO Viehbacher on Stirring Innovation in the Era of R&D Cutbacks

Luke Timmerman

01/17/12

National